Inter-element matrix in ultrasound contrast agents populations to measure transport parameters

Patent metadata

Field	Value
Publication number	US-11607197-B2
Application number	US-201816767188-A
Country	US
Kind code	B2
Filing date	Nov 27, 2018
Priority date	Nov 27, 2017
Publication date	Mar 21, 2023
Grant date	Mar 21, 2023

Abstract

Systems and methods for measuring micro-architectural properties of vascular networks are described herein. An example method can include injecting an ultrasound contrast agent into a medium, and transmitting a plurality of acoustic pulses into the medium using a ultrasound transducer array. Each respective acoustic pulse can be transmitted from one or more elements of the ultrasound transducer array. The method can also include receiving a plurality of backscattered signals with the ultrasound transducer array in response to each respective acoustic pulse, and obtaining a response matrix including the backscattered signals. The method can further include extracting a coherent or incoherent contribution to the backscattered signals from the response matrix, and quantifying a property of a vascular network based on the coherent or incoherent contribution to the backscattered signals.

First claim

What is claimed:

1. A system, comprising:
an ultrasound transducer array configured to transmit a plurality of acoustic pulses into a medium, wherein the medium includes a vascular network populated by an ultrasound contrast agent comprising microbubbles, wherein each respective acoustic pulse is transmitted from one or more transducer elements of the ultrasound transducer array; and
a computing device comprising a processor and a memory operably coupled to the processor, wherein the memory has computer-executable instructions stored thereon that, when executed by the processor, cause the processor to:
receive a plurality of backscattered signals, wherein each backscattered signal is separately received by each of the plurality of transducer elements in the ultrasound transducer array in response to each respective acoustic pulse;
obtain a response matrix comprising the backscattered signals;
extract a coherent contribution to the backscattered signals from the response matrix and quantify a vessel density or an anisotropy metric of the vascular network based on the coherent contribution to the backscattered signals, or extract an incoherent contribution to the backscattered signals from the response matrix and quantify the vessel density or the anisotropy metric of the vascular network based on the incoherent contribution to the backscattered signals, wherein the backscattered signals are induced by the ultrasound contrast agent and the medium;
differentiate, based at least in part on the quantified vessel density or the quantified anisotropy metric, between healthy and tumoral tissues; and
provide the quantified vessel density or the quantified anisotropy metric on a display device.

2. The system of claim 1 , further comprising an injection device configured to inject the ultrasound contrast agent into the medium.

3. The system of claim 2 , wherein a concentration of the microbubbles is less than 0.5% (5×10 6 microbubbles/mL) bubble concentration by volume.

4. The system of claim 2 , wherein a concentration of the microbubbles is between 0.5% (5×10 6 microbubbles/mL) and 2% (2×10 7 microbubbles/mL) bubble concentration by volume.

5. The system of claim 1 , wherein the backscattered signals are received at a subset of transducer elements of the ultrasound transducer array in response to each respective acoustic pulse.

6. The system of claim 1 , wherein extracting the coherent contribution to the backscattered signals or extracting the incoherent contribution to the backscattered signals comprises determining a diffusion constant of the medium.

7. The system of claim 6 , wherein the incoherent contribution to the backscattered signals is extracted from the response matrix, and wherein the diffusion constant of the medium is determined using the incoherent contribution to the backscattered signals.

8. The system of claim 6 , wherein the coherent contribution to the backscattered signals is extracted from the response matrix, and wherein the diffusion constant of the medium is determined using the coherent contribution to the backscattered signals.

9. The system of claim 6 , wherein the memory has further computer-executable instructions stored thereon that, when executed by the processor, cause the processor to estimate a scattering or transport mean free path using the diffusion constant of the medium.

10. The system of claim 9 , wherein the memory has further computer-executable instructions stored thereon that, when executed by the processor, cause the processor to generate a map of the scattering or transport mean free path over a dimension of a tumor.

11. The system of claim 1 , wherein the quantified vessel density is correlated to a scattering or transport mean free path, or the quantified vessel density is the number of blood vessels per unit of tissue volume.

12. The system of claim 1 , wherein the quantified anisotropy metric is related to respective scattering or transport mean free paths for at least two orientations of the ultrasound transducer array.

13. The system of claim 12 , wherein the ultrasound transducer array is rotated over the vascular network to obtain measurements in the at least two orientations.

14. The system of claim 1 , wherein the system is a catheter or an ultrasound scanner.

15. The system of claim 1 , wherein the acoustic pulses have a frequency of between 1 MHz and 15 MHz.

16. The system of claim 1 , wherein the memory has further computer-executable instructions stored thereon that, when executed by the processor, cause the processor to detect or diagnose a tumor based on the quantified vessel density or the quantified anisotropy metric.

17. The system of claim 1 , wherein the memory has further computer-executable instructions stored thereon that, when executed by the processor, cause the processor to detect the presence of angiogenesis based on the quantified vessel density or the quantified anisotropy metric.

18. The system of claim 1 , wherein the vascular network comprises a plurality of blood vessels, and wherein a majority of the blood vessels of the vascular network have a diameter less than 1 millimeter (mm).

19. The system of claim 1 , wherein the ultrasound transducer array comprises at least one of a two-dimensional, curved, or circular transducer.

20. The system of claim 1 , wherein no images are created using the plurality of backscattered signals.

Assignees

• Univ North Carolina State
• Univ North Carolina Chapel Hill

Inventors

• Muller Marie
• Dayton Paul
• Joshi aditya

Classifications

• A61B8/0891

  for diagnosis of blood vessels · CPC title

• A61B8/481 Primary

  involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream · CPC title

• A61B8/12

  in body cavities or body tracts, e.g. by using catheters · CPC title

• A61B5/4839

  combined with drug delivery · CPC title

• A61B8/5223 Primary

  for extracting a diagnostic or physiological parameter from medical diagnostic data (for algorithms to analyse biomedical images G06T7/0012) · CPC title